Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 61 shares at $205.95 ($13K) on 2019-11-15, disclosed to the SEC on 2019-11-19.
Scheduled sale ($13k) by EVP and CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |